ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment
1 clinical trials · Condition
◉ Watch ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment
| Record | Firm | Date |
|---|---|---|
| An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer (NCT01677455) | Synta Pharmaceuticals Corp. | 2012-07-01 |
Track ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment automatically
Every clearance here is in the API, with alerts when new ones post.